It's been just over a year since Japan's Nippon Steel bought U.S. Steel, after agreeing to invest $11 billion into the Pittsburgh-based icon by the end of 2028. - Thus far, almost all of that money remains a promise. By the numbers: Nippon had invested less than $200 million through the end of March, according to recent disclosures. - It expects to have invested a total of $580 million through the end of August, as part of $3.2 billion in approved projects (the largest of which isn't slated to end until early 2029). - Nippon reaffirmed its $11 billion investment pledge, but didn't provide allocation info on the remaining $7.8 billion. Catch up quick: The Biden administration had blocked Nippon's acquisition on national security grounds…
It's been just over a year since Japan's Nippon Steel bought U.S. Steel, after agreeing to invest $11 billion into the Pittsburgh-based icon by the end of 2028. - Thus far, almost all of that money remains a promise. By the numbers: Nippon had invested less than $200 million through the end of March, according to recent disclosures. - It expects to have invested a total of $580 million through the end of August, as part of $3.2 billion in approved projects (the largest of which isn't slated to end until early 2029). - Nippon reaffirmed its $11 billion investment pledge, but didn't provide allocation info on the remaining $7.8 billion. Catch up quick: The Biden administration had blocked Nippon's acquisition on national security grounds…Open
South Carolina attorney Eric Bland joins “Jesse Weber Live” to discuss the latest developments in the Alex Murdaugh retrial, which is now tentatively scheduled for April 2027. #alexmurdaugh #retrial #witnesses "Jesse Weber Live" brings a fresh, fast-paced, and often unexpected take on the day’s headlines, diving into the biggest stories through the lens of legal expertise.
On Tuesday’s “Finnerty,” Jonathan Choe, Link Lauren, and Jaimee Michell weighed in on the Seattle Pride parade, remarking on several naked individuals seen marching in the parade.
A California company partnering with the Pentagon to develop an antidote for venomous snakebites is in animal trials to gauge the drug’s suitability for humans.
